GoldenGolden
Allergan

Allergan

Allergan is a small Molecules, Biologics founded in 2015 by Allen Chao.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

June 25, 2019
The drugmaker AbbVie announces it plans to buy Allergan, the maker of Botox, for about $63 billion.

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
AbbVie
June 25, 2021
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has informed the company that the FDA will not meet the...
AbbVie
June 25, 2021
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a...
Research and Markets
June 17, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Anti-Parkinson Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's...
June 15, 2021
BioSpace
Visus Therapeutics Announces Executive Leadership Appointments in Operations, Research, Clinical Operations and Intellectual Property - read this article along with other careers information, tips and advice on BioSpace
AbbVie
June 2, 2021
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced results of an analysis from the Phase 3 SELECT-PsA 2 clinical trial, showing that continuous treatment with...
AbbVie
June 2, 2021
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new analyses to be presented at the EULAR 2021 Virtual Congress showing patients with moderate to severe...
BioSpace
May 20, 2021
BioSpace
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced today the appointment of Sanjiv K. Patel, MBBS, MA, MBA, to its Board of Directors.
BioSpace
May 12, 2021
BioSpace
Bioniz Therapeutics, Inc., ("Bioniz"), a clinical-stage biopharmaceutical company advancing a pipeline of first-in-class peptide-based multi-cytokine inhibitors for the treatment of cancer and autoimmune diseases, announced today the appointment of Eric Carter, M.D., Ph.D., to the Board of Directors (BOD), and the hiring of Simon Daggett as Vice President, Clinical Operations and Project Management.
AbbVie
April 30, 2021
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial results for the first quarter ended March 31, 2021. "We are off to an excellent start to 2021, with...
Research and Markets
March 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Biosimilar Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to...
AbbVie
February 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE: ABBV) announced financial results for the fourth quarter and full year ended December 31, 2020. "We successfully completed the...
Ben Adams
January 5, 2021
FierceBiotech
Sosei has become the latest victim of AbbVie's post-Allergan merger clear-out as the new suitor has decided to dump its former partner.
AbbVie
January 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive top-line results from two Phase 3 studies in adults with active psoriatic arthritis, KEEPsAKE-1...
Sosei Heptares
January 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) announces it is to regain the worldwide rights to its muscarinic agonist programs. The...
Camille Samuels
December 23, 2020
Business Insider
Venrock partner Cami Samuels says to communicate using the Goldilocks principle and don't hire a banker until you have a term sheet.
AbbVie
December 11, 2020
www.prnewswire.com:443
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP)...
Research and Markets
December 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- The "Global Intragastric Balloon Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global intragastric balloon...
Research and Markets
November 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- The "Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
Alex Keown
May 22, 2020
BioSpace
Pharma and life sciences companies bolster their executive leadership teams and boards with these Movers & Shakers.
BioSpace
May 18, 2020
BioSpace
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Matthew Walsh and Rachel Stahler as Chief Financial Officer and Chief Information Officer, respectively, for Organon & Co., its intended spinoff of its women's health, legacy brands and biosimilars businesses.
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.